CTRI/2018/01/011617已完成4 期
A Randomized, Double Blind, Placebo Controlled, Four Arm, Parallel Group Study To Evaluate The Comparative Efficacy Of Different Forms And Doses Of Curcumin With That Of A Placebo In Active Rheumatoid Arthritis Patients.
Plant Lipids P Limited0 个研究点目标入组 45 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •i.Patients with active RA for at least one (1) year, diagnosed according to the revised 1987 American College of Rheumatology (ACR) criteria for the classification of rheumatoid arthritis.
- •ii.Receiving treatment on an outpatient basis.
- •iii.Active disease at the time of screening.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
OLNP-08 for the Treatment in Reducing Symptoms of Knee OsteoarthritisCTRI/2017/06/008874Olene Life Sciences Private Limited
进行中（未招募）
不适用
A Randomized, Double-blind, Placebo Controlled Parallel-group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients with Early Stage Parkinson’s Disease - The Rembrandt studyParkinson's Disease Early StageEUCTR2005-006033-32-SESolvay Pharmaceuticals440
进行中（未招募）
不适用
A Randomized, Double-blind, Placebo Controlled Parallel-group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients with Early Stage Parkinson’s Disease - The Rembrandt studyParkinson's Disease Early StageEUCTR2005-006033-32-FISolvay Pharmaceuticals440
进行中（未招募）
不适用
A Randomized, Double-blind, Placebo Controlled Parallel-group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients with Early Stage Parkinson’s Disease - The Rembrandt studyParkinson's Disease Early StageEUCTR2005-006033-32-SKSolvay Pharmaceuticals440
已完成
不适用
Clinical Study to evaluate the Efficacy and Safety of EASY CLIMB CAPSULES in Patients with Painful knee Osteoarthritisâ??CTRI/2014/11/005205atsyn Catalysts50